<DOC>
	<DOCNO>NCT02904070</DOCNO>
	<brief_summary>Prematurity lead cause mortality perinatal morbidity . Despite many preventive measure use tocolytic therapy , incidence premature birth decrease recent decade . In 2010 preterm birth rate ( single child , born alive ) still 5.5 % France 11 % population Reunion . In 50 % case , premature birth relate spontaneous premature labor layout without rupture amniotic membrane , call threat premature birth.The threat premature birth , define combination cervical modification regular painful uterine contraction 22 week amenorrhea 36 week amenorrhea + 6days , major cause hospitalization pathological pregnancy service . But threat premature delivery situation cause premature delivery . In service , 30 % patient hospitalize threat premature delivery give birth prematurely accordance publish international data . The diagnosis threat premature delivery difficult still possible differentiate `` false labour '' `` real labour '' . Currently diagnosis threat premature delivery routine base combination vaginal examination , ultrasound , cervical length , strategy lack specificity . In absence prognostic tool predict reliably risk premature delivery situation threat premature delivery , medical care maximalist . : hospitalization , conduct paraclinical investigation , prescription tocolytics treatment conduct antenatal corticotherapy . seem particularly necessary identify efficient prognostic criterion clinic ultrasound judge severity threat premature delivery word predict risk premature delivery adapt adjust care patient diagnosis threat premature delivery .</brief_summary>
	<brief_title>Interest Placental Alpha-microglobulin-1 Detection Test Assess Risk Premature Delivery Reunion Island</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<criteria>All patient receive programmed emergency consultation ; Pregnant , 24 week amenorrhea 33 week amenorrhea + 6 day ; With painful regular uterine contraction confirm monitoring ; Patient affiliate social security scheme ; Informed consent sign patient adult legal representant minor subject cervical cerclage placement ; prove vaginal infection and/or vaginal ongoing treatment ;</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Threat</keyword>
</DOC>